Insights into Practice: Tiefenbacher Group at the University of Kiel and Dusseldorf
Last week, Tiefenbacher Group had the fantastic opportunity to get in touch with pharmacy students at the University of Kiel and the University of Düsseldorf, to provide them insights into practice.
Together with our Managing Director Dr. Kristian Ruepp, Dr. Simon Bock from Market Access and Digital Strategy, and Dr. Patrick Indorf from Research & Development, two real-life cases were presented in Kiel. Along with Laura Sophie Steinecker from Research & Development and Dr. Kristian Ruepp, an additional “from API Distribution to Formulation Development” presentation occurred in Düsseldorf. Both events highlighting the challenges and innovations of the pharmaceutical industry. By sharing insights into our work, we aim to inspire the next generation of curious, healthcare-passionate talents. We want them to challenge the status quo and explore opportunities in the pharmaceutical industry.
Gratitude is extended to Prof. Dr. Regina Scherließ from Kiel University for the opportunity to participate in this lecture. Additionally, thanks to Prof. Dr. Jörg Breitkreutz from Düsseldorf University for allowing contributions to a lecture in the relatively new Master of Science in Industrial Pharmacy program.
A career in the pharmaceutical industry
We look forward to staying in touch with these talented students. Moreover, we are happy to play a part in helping them choose a career in the pharmaceutical industry – maybe they will shape a successful future with us at Tiefenbacher Group.
If you are also interested in a presentation by us for your university or if you are a student looking for an internship during your practical year, please contact our Human Relations Team around Marie-Theres Blumers, Chantal Gärtner and Johanna Boettcher.
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health solutions. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on: www.tiefenbachergroup.com
